Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRIDER NZAus sildenafil trial for severe early-onset fetal growth restriction
ACTRN12612000584831Phase 3Completed
- Sponsor
- The University of Auckland
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in intrauterine growth restriction (IUGR) comparing Sildenafil with Placebo (2 arms). Primary endpoint: Proportion of pregnancies with increased abdominal circumference growth velocity after treatment compared with pretreatment. Started Mar 2014; status: completed.
02
Drugs
sildenafil
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on ACTRN12612000584831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000584831.